Calendar Elicio Therapeutics, Inc.

Equities

ELTX

US28657F1030

Real-time Estimate Cboe BZX 11:40:09 24/05/2024 pm IST 5-day change 1st Jan Change
8.045 USD -9.10% Intraday chart for Elicio Therapeutics, Inc. -5.65% +6.12%

Chart calendar Elicio Therapeutics, Inc.

90135e.RepBAcySAMrDAru-dxuasxjWv_i7HERePnpshtkft60.B4MHR6blUaSuZ-LzLWHuiki-7YDPMSgKekk64LNZ4-k9nTNCiudXua5a4g~11cca5209e8edc65af1bd1ee7e4e6328

Upcoming events on Elicio Therapeutics, Inc.

01/06/2024 07:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No: 2636
09/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
28/03/2025 Q4 2024 Earnings Release (Projected)
14/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Elicio Therapeutics, Inc.

09/04/2024 09:30 pm American Association for Cancer Research Meeting - Abstract Number: 4099
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Abstract Number: 4100
09/04/2024 02:00 am American Association for Cancer Research Meeting - Abstract Number: CT107
29/03/2024 06:00 pm Q4 2023 Earnings Release
20/03/2024 Benzinga Virtual Healthcare Summit
13/02/2024 11:10 pm Oppenheimer Healthcare Life Sciences Conference
20/01/2024 02:00 am American Society of Clinical Oncology Gastrointestinal Cancers Conference - Abstract No #: TPS720
19/01/2024 01:00 am B. Riley Securities Oncology Conference
18/01/2024 ASCO Gastrointestinal Cancers Symposium
06/12/2023 09:00 pm H.C. Wainwright Precision Oncology Virtual Conference
10/11/2023 03:00 am Q3 2023 Earnings Release
05/11/2023 05:40 am Society for Immunotherapy of Cancer Meeting - Abstract NO:656
04/11/2023 07:30 am Society for Immunotherapy of Cancer Meeting - Abstract N0:1145
30/09/2023 02:10 am AACR Conference
13/09/2023 07:00 pm H.C. Wainwright Global Investment Conference
11/08/2023 06:00 pm Q2 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-35,7
-32,5
-10.14%

-44,1

Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

Net income
Million USD
Released
Forecast
Spread
-28,2


0,00
0,00
-

0,00

EPS
USD
Released
Forecast
Spread
-1,62


0,00
0,00
-

0,00

Announcement Date29/03/2329/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-10,8
-6,83
-57.63%
-9,39
-9,30
-0.99%
-10,2
-11,5
10.65%

-10,8


-11,3


-11,9

Announcement Date09/11/2329/03/2415/05/24---

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELTX Stock
  4. Calendar Elicio Therapeutics, Inc.